Health ConditionsSeborrheic dermatitis (SD) and dandruff are of a continuous spectrum of the same disease that affects the seborrheic areas of the body. Dandruff is restricted to the scalp, and involves itchy, flaking skin without visible inflammation. Generally, dandruff is considered the mildest form of seborrheic dermatitis from a clinical perspective since inflammation is minimal and typically subclinical. Mild seborrheic dermatitis of the scalp may be described in lay terms as dandruff due to the dry, flaky character of the skin. However, as dandruff may refer to any dryness or scaling of the scalp, not all dandruff is seborrheic dermatitis.
Dandruff, alternatively referred to in the literature as pityriasis simplex, furfuracea, or capitis, is a skin disorder characterized by flaking, itching, and microinflammation. By definition, dandruff is confined to the scalp, and it is experienced by about half of the adult population irrespective of ethnicity and gender. Inflammation and the presence of lesions outside the scalp exclude the diagnosis of dandruff.
Seborrheic dermatitis can affect the scalp as well as other seborrheic areas, and involves itchy and flaking or scaling skin, inflammation, and pruritus. Flaking in SD and dandruff is usually white-to-yellowish, and may be oily or dry.
The global prevalence of seborrheic dermatitis is estimated at 4.38% (95% CI, 3.58–5.17%), with higher rates observed in adults (5.64%) compared to children (3.70%) and neonates (0.23%). There is considerable geographical variation, with the highest prevalence reported in South Africa (8.82%) and the lowest in India (2.62%). Dandruff, the mildest form of this dermatitis, is probably far more common and is present in an estimated 15–20% of the population. In the United States alone, $300 million is spent annually on dandruff over-the-counter treatments.
The condition has two incidence peaks: the first in the first three months of life, and the second beginning at puberty and reaching its peak at 40–60 years of age. SD affects newborns, infants, and adults, occurs in persons of all races, and the clinical syndrome is more severe in males than in females.
Characterized by folliculocentric salmon-colored papules and plaques with a fine white scale and a yellowish crust (often described as a greasy scale-crust), seborrheic dermatitis manifests diversely across different body areas and may present in multiple locations. Pruritus is the most frequent symptom, with variable intensity among patients, and is most commonly reported on the scalp. Some authors consider dandruff a non-inflammatory form of SD, characterized by fine white scales without underlying erythema.
Areas of the skin rich in oil-producing glands are often affected, including the scalp, face, and chest. It can result in social or self-esteem problems.
The body systems involved in dandruff and seborrheic dermatitis span several domains:
Dandruff is one of the accelerated epidermal growths resulting in retention of nuclei that have not had sufficient time to completely mature in the cells of the stratum corneum. Dandruff scale comprises a cluster of corneocytes which have retained a large degree of cohesion with one another and which become detached as such from the surface of the stratum corneum.
Dandruff results from at least three etiologic factors: Malassezia fungi, sebaceous secretions, and individual sensitivity. While Malassezia (formerly P. ovale) has long been a suspected cause, implicated by its presence on skin and lipophilic nature, lack of correlation between Malassezia number and the presence and severity of dandruff has remained perplexing.
Malassezia spp. lack fatty acid synthase genes; hence, they satisfy their obligate need for fatty acids by secreting multiple lipases that metabolize triglycerides in sebaceous lipids on the scalp surface to release free fatty acids. These free fatty acids also act as skin irritants and induce inflammatory responses that are typical of dandruff.
Malassezia organisms are probably not the cause of seborrheic dermatitis but a cofactor linked to T-cell depression, increased sebum levels, and activation of the alternative complement pathway. Malassezia was increased 1.5 to 2 times (75% of flora) in dandruff.
The pathophysiology of SD remains incompletely understood. Several contributing factors have been identified, including seborrhea, cutaneous microbiome dysbiosis (particularly overgrowth of Malassezia spp.), epidermal barrier dysfunction, and an altered immune response involving Th1, Th17, Th2, and Th22 pathways.
Genetic factors appear to modulate susceptibility to seborrheic dermatitis. Variations in genes involved in skin barrier regulation, lipid metabolism, and immune response may predispose certain individuals to more severe or persistent disease.
Yeast of the genus Malassezia has long been regarded as a main predisposing factor, even though a causal relationship has not been firmly established. Additional predisposing factors have been described, including sebaceous activity, host immunity (especially HIV infection), epidermal barrier integrity, skin microbiota, endocrine and neurologic factors, and environmental influences.
Among individuals living with HIV, SD affects 20% to 83% of patients, particularly those with advanced immunosuppression or AIDS, and is often regarded as a clinical marker of immune status. In patients with Parkinson's disease, the prevalence ranges from 52% to 59%, with seborrheic dermatitis reported in over half of cases. Patients with parkinsonism frequently present with seborrhea (oily skin) and seborrheic dermatitis, both of which may improve with L-DOPA therapy.
Viral infections (HIV, HCV, SARS-CoV-2), neurological disorders such as Parkinson's disease, and psychological stress have all been associated with increased disease susceptibility.
Seborrheic dermatitis is commonly aggravated by changes in humidity, changes in seasons, trauma (e.g., scratching), or emotional stress. Previously identified factors associated with SD prevalence are stress, smoking, hypertension, HIV, Parkinson's disease, obesity, immunosuppression, and environmental properties, especially climate factors such as humidity and temperature. It is well-established that SD severity may vary over time, and a recent study found that SD appeared to demonstrate an increasing frequency in light-skin populations during the winter.
Seborrheic dermatitis tends to be worse in colder, drier climates and improves during summer months, especially with ultraviolet exposure.
Zinc deficiency in patients with acrodermatitis enteropathica, riboflavin, pyridoxine, and niacin deficiency can manifest as a seborrheic dermatitis-like rash. A 2024 systematic review (JMIR Dermatology, 13 studies, 13,906 patients) found that: a total of 13 studies, including 8 case-control, 3 cross-sectional, and 2 randomized controlled trials, were included. Seborrheic dermatitis was correlated with significantly increased copper, manganese, iron, calcium, and magnesium concentrations and significantly lower serum zinc and vitamin D and E concentrations.
Zinc plays multiple roles in skin health, including supporting immune function, keratinocyte differentiation, and sebaceous gland regulation. Seborrheic dermatitis has been correlated with significantly lower serum zinc concentrations in the 2024 systematic review cited above. More studies are needed to identify if this relationship holds true for severe seborrheic dermatitis and if oral zinc supplementation is of clinical benefit. Topically, zinc pyrithione and selenium sulfide are over-the-counter products that reduce Malassezia furfur proliferation. The mechanism of topical zinc pyrithione action against Malassezia restricta has been studied in depth at the molecular level. Numerous studies have shown that zinc pyrithione, ketoconazole, and selenium sulfide improve seborrheic dermatitis. The evidence for oral zinc supplementation in dandruff remains associative and requires interventional confirmation.
Seborrheic dermatitis was correlated with significantly lower serum vitamin D concentrations in the 2024 systematic review. This association is consistent across multiple study designs, but interventional studies evaluating serum zinc, vitamin D, and vitamin E supplementation for seborrheic dermatitis are lacking. The negative consequences of a Western diet, alcohol use, obesity, and the benefits of fruit consumption are well known; however, to fully understand their specific relationships to seborrheic dermatitis, further cohort or interventional studies are needed.
Vitamin E is a fat-soluble vitamin and an important antioxidant that helps protect cell membranes from lipid peroxidation, minimizing oxidative damage. Therefore, the low levels of vitamin E in patients with seborrheic dermatitis may contribute to an increased oxidative burden. Supplementation with oral vitamin E showed early promising results in improving other inflammatory skin diseases, including atopic dermatitis and psoriasis. Further research is needed to elucidate the role of vitamin E supplementation as an adjunctive therapy in seborrheic dermatitis. Evidence is preliminary and no direct interventional trials in SD patients have been reported in the systematic review literature.
Riboflavin (B2), pyridoxine (B6), and niacin deficiencies can manifest as seborrheic dermatitis-like rash. These associations come largely from case reports and observational data in deficiency states rather than from interventional trials in the general dandruff population. Biotin has been used in infants with seborrheic dermatitis — both treating the infant directly and treating the breastfeeding mother. Results have been mixed, and there are no trials in adults. The overall evidence for B vitamins in dandruff specifically is weak and mainly based on case-level observations and deficiency syndromes.
Omega-3 fatty acids have been shown to decrease the production of inflammatory compounds. Ideally, omega-3 fatty acids would come from foods such as fatty fish (salmon, mackerel, and sardines), flaxseeds, and walnuts. While omega-3s have broad anti-inflammatory evidence in other inflammatory skin diseases, no dedicated randomized controlled trials specifically on dandruff and omega-3 supplementation were identified in the peer-reviewed systematic review literature. The VA Whole Health Library cites omega-3s as a nutritional consideration in seborrheic dermatitis on the basis of their general anti-inflammatory mechanisms, but this evidence is indirect.
Traditional Use: Leaves of the Australian tea tree plant Melaleuca alternifolia were used traditionally by First Nations Australians for treating wounds, burns, and insect bites. Its application to scalp and hair conditions is a more modern extension of this tradition.
Scientific Evidence: Tea tree oil is the most studied natural agent for dandruff with human clinical trial data. Tea tree oil has antifungal properties with activity against P. ovale (now Malassezia) and may be useful in the treatment of dandruff. A randomized, single-blind, parallel-group study was conducted to investigate the efficacy and tolerability of 5% tea tree oil and placebo in patients with mild to moderate dandruff. One hundred twenty-six male and female patients, aged 14 years and older, were randomly assigned to receive either 5% tea tree oil shampoo or placebo, which was used daily for 4 weeks. The 5% tea tree oil shampoo group showed a 41% improvement in the quadrant-area-severity score compared with 11% in the placebo group (P < .001). This is published in the Journal of the American Academy of Dermatology (Satchell et al., 2002). Tea tree oil has a distinctive odor, so patients were likely to know their treatment group status, which represents a limitation due to the single-blind design. Overall, the evidence for topical 5% tea tree oil is moderate-strength for mild-to-moderate dandruff based on a single, adequately powered RCT. Replication in double-blind trials is needed.
Traditional Use: Aloe vera has been used for centuries in traditional medicine across Africa, the Middle East, and Asia for inflammatory skin conditions, wound healing, and scalp care. Its topical use for itchy, flaking scalp conditions is documented in Ayurvedic and folk traditions.
Scientific Evidence: The anti-dandruff potential of aloe vera was demonstrated in a clinical trial involving 44 individuals suffering from seborrheic dermatitis of the scalp. For six weeks, half of the participants applied an aloe vera-based cream twice a day, while the others applied a placebo cream. At the end of the study, a significantly greater improvement was observed in the patients from the first group (58% versus 15%) in terms of erythema, itching, and scaling. Although more evidence is still needed, aloe vera appears to be a promising natural alternative for combating dandruff. This trial (Vardy et al., 1999, Journal of Dermatological Treatment) was small and of relatively short duration. The evidence is preliminary.
Traditional Use: Growing in tropical and subtropical regions, neem has been used in Ayurvedic, Siddha, and herbal medicine for thousands of years. With approximately 135 bioactive compounds identified across various parts of the tree, neem formulations effectively treat numerous conditions, including ulcers, eczema, sores, burns, and infections, underscoring their significance as a versatile and holistic natural remedy. Topical application of neem leaf paste and neem oil to the scalp for dandruff is a long-standing practice in South and Southeast Asian traditional medicine.
Scientific Evidence: Neem leaf extracts have demonstrated antidermatophytic activity against various dermatophytes, highlighting its potential to fight fungal infections on the scalp. While these findings are encouraging, more robust clinical trials in humans are necessary to fully confirm neem's effectiveness and safety for dandruff treatment. Current evidence is largely in vitro or from small, uncontrolled studies. High-quality human RCTs are absent.
Though not traditional herbal ingredients, these mineral-based compounds bear nutritional relevance through their relationship to zinc and selenium biology.
Zinc Pyrithione: Zinc pyrithione is an over-the-counter product that reduces Malassezia furfur proliferation. Its mechanism involves disruption of the fungal membrane and transport systems. Multiple randomized controlled trials support its efficacy in dandruff and seborrheic dermatitis.
Selenium Sulfide: The efficacy of 2.5% selenium sulfide was confirmed in a 3-arm, randomized controlled trial involving 246 patients with moderate to severe dandruff who received shampoos containing 2.5% selenium sulfide, 2% ketoconazole, or placebo. Selenium sulfide 2.5% shampoo was found to have higher cytostatic and keratolytic activities and lower cytotoxic activity than shampoos containing 2% ketoconazole, 1% zinc pyrithione, or 2% ketoconazole + 1% zinc pyrithione.
Scientific Evidence: The relationship between probiotics and seborrheic dermatitis is primarily mediated through modulation of the cutaneous microbiome and, to a lesser extent, the gut–skin axis. SD is characterized by a dysbiotic profile with increased abundance of Malassezia spp. Supplementation with Lactobacillus paracasei ST11 significantly improved dandruff, erythema, and seborrhea by suppressing Th1/Th2 cytokines and upregulating IL-10/TGF-β. A study published in the Journal of Beneficial Microbes had 60 adult men with moderate to severe dandruff take either a daily probiotic or placebo for 56 days. Results showed significant improvements in dandruff in the probiotic group compared to the placebo. Despite these preliminary findings, at present, no dermatological guidelines recommend the routine use of probiotics for SD, and their application should be considered experimental and individualized until high-quality, long-term randomized controlled trials are available.
Regarding prebiotics, Triphala is a traditional Ayurvedic remedy that consists of a blend of three dried fruits. Triphala is considered a prebiotic, and a study in the Journal of Dermatological Treatment assessed its effectiveness in seborrheic dermatitis, specifically in reducing oil production on the scalp. The prebiotic Triphala improved patient satisfaction and decreased scalp sebum levels over 8 weeks. This finding came from one RCT included in the 2024 systematic review; evidence remains limited.
The most comprehensive evidence on diet and seborrheic dermatitis comes from a 2024 systematic review published in JMIR Dermatology (Woolhiser et al.), which included 13 studies and 13,906 patients. Key findings:
Most studies find associations between regular alcohol use and seborrheic dermatitis. The mechanism is not fully elucidated but may involve immune modulation, nutritional depletion (particularly of B vitamins and zinc), and altered skin microbiome composition.
Stress can play a role in initiating or worsening flares of seborrheic dermatitis and dandruff. The condition is commonly worsened by changes in environmental humidity, changes in seasons, trauma (e.g., scratching), or emotional stress. The proposed mechanism involves stress-driven dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis and subsequent immune suppression, which may enable Malassezia overgrowth.
In many countries, there is a seasonal dependence of the disease with a peak in winter. Seborrheic dermatitis tends to be worse in colder, drier climates and improves during summer months, especially with ultraviolet exposure. The improvement with UV exposure may be related to its anti-inflammatory and antimicrobial effects on the scalp microenvironment, as well as facilitation of vitamin D synthesis.
Microbiomes exist in multiple areas of the body, including the skin, and it is thought that these microbes interact. Evidence suggests the gut microbiome can affect the skin microbiome and alter the immune and inflammatory response. Growing interest in the microbiome as a therapeutic target suggests that microbiome-directed interventions may evolve into valuable adjuncts or alternatives to conventional antifungals, particularly in patients with recurrent disease, sensitive skin, or corticosteroid aversion. Research in this area remains early-stage for dandruff specifically.
Obesity has been identified as a factor associated with SD prevalence. However, the association between BMI and obesity on seborrheic dermatitis severity and prevalence is mixed across available studies, and no causal relationship has been established.
A double-blind, placebo-controlled RCT (n=44 adults) found that a 30% crude Aloe vera emulsion significantly reduced scalp scaling (36.6% vs. 17.6% placebo) and itching (21.5% vs. 5.3%) in seborrheic dermatitis over 4 weeks. Dermatologist-assessed global improvement was 58% (aloe) vs. 15% (placebo; p=0.009). In vitro studies confirm antifungal activity of aloe vera against Malassezia furfur.
Geranium EO has in vitro demonstrated antifungal activity against Malassezia, the primary fungal cause of dandruff. This provides a mechanistic basis for its traditional use in dandruff-prone scalp conditions. Human clinical trials for this specific indication have not been conducted.
A published clinical trial (Al-Waili, Eur J Med Res, 2001; n=30 patients) found that topical application of 90% crude honey every other day for 4 weeks produced significant improvement in dandruff and seborrheic dermatitis, with all patients improving and no relapse during 6-month maintenance. Honey's mechanism involves osmotic antimicrobial action against Malassezia, hydrogen peroxide generation, and antifungal polyphenols.
Clinical evidence shows lemongrass oil, when formulated into shampoo, reduces scalp flakiness. A pilot clinical study found lemongrass shampoo reduced dandruff, and laboratory work confirms antifungal activity against Malassezia furfur, the primary pathogen associated with dandruff. Effect is present but less potent than tea tree oil in comparative evaluations.
A randomized, single-blind, parallel-group trial (n=126) found that a 5% tea tree oil shampoo produced a 41% improvement in dandruff severity scores vs. 11% for placebo (p<0.001). Tea tree oil exerts antifungal activity against Pityrosporum ovale (Malassezia), the primary yeast implicated in dandruff. It is recognized as an antimicrobial natural product in pharmaceutical anti-dandruff formulations.
Neem (Azadirachta indica) has documented antifungal activity against Malassezia, the primary dandruff-causing yeast. A 2024 Scientific Reports study showed a standardized neem-containing extract had superior efficacy against Malassezia furfur compared to ketoconazole in vitro. A quasi-experimental clinical study found topical neem leaf paste significantly reduced dandruff severity. Neem has long-standing traditional Ayurvedic use for scalp conditions.
A 2024 Scientific Reports study (PMC) showed that a standardized rosemary-neem combined extract had superior antifungal activity against Malassezia furfur compared to ketoconazole, with confirmed anti-inflammatory activity and scalp penetration. A PubMed review explicitly names rosemary oil among essential oils with recognized anti-dandruff potential. Rosemary has traditional use in Mediterranean hair care for dandruff control.
Zinc pyrithione is an FDA-approved OTC anti-dandruff active used for over 50 years and is the most widely used anti-dandruff compound globally. Case-control studies show significantly lower serum zinc in seborrheic dermatitis patients vs. healthy controls (p=0.045). Topically, zinc exerts antifungal activity against Malassezia and regulates sebum production. It is one of only five FDA-approved anti-dandruff actives in the United States.
Galangal rhizome is listed in traditional South and Southeast Asian medicine for scalp conditions including scurf (dandruff-like scaling). The antifungal activity of its essential oil against Malassezia-related fungi provides a plausible mechanistic basis. No clinical trials for dandruff exist.
Topical ACV rinses for dandruff are a documented traditional remedy, supported by ACV's acidic pH (potentially balancing scalp pH) and in vitro antifungal activity against Malassezia-related organisms. No human clinical trials specifically for dandruff exist. The practice is widely referenced in traditional and home-remedy contexts.
Arnica has a long-established use in commercial shampoos, hair tonics, and anti-dandruff preparations, recognized in the HerbalGram/AHPA literature and noted in the EMA assessment report. The antimicrobial and anti-inflammatory properties of arnica sesquiterpenes are cited as the pharmacological basis. No clinical trials for dandruff specifically have been published.
Birch leaves and birch water have a documented traditional use for dandruff and seborrheic scalp conditions. Birch bark's antimicrobial and anti-inflammatory properties are considered mechanistically relevant. No controlled clinical trials specifically for dandruff have been identified.
Cajuput oil's documented antifungal activity against Candida and other fungi, combined with its traditional use for scalp and skin conditions, underpins a traditional claim for dandruff, which is frequently driven by the fungus Malassezia. No specific clinical studies on cajuput for dandruff exist.
Goldenseal is used in traditional herbal practice for scalp conditions including dandruff, based on its antifungal properties against Malassezia and antimicrobial activity. This is an extension of its documented use for skin and scalp disorders.
Traditional healers across India, Tibet, China, and Sri Lanka have prescribed amla specifically for dandruff for centuries. Food Revolution documents this as one of amla's traditional uses. Amla oil's antifungal properties provide a mechanistic basis.
Indigo leaves have a well-documented traditional use in Ayurvedic and folk medicine for dandruff control, applied to the scalp as oil or paste. Antimicrobial and anti-inflammatory properties provide a plausible mechanism. No clinical trials exist for this specific application.
Topical application of Quillaja bark extract or powder to the scalp to relieve itchiness and dandruff is one of the two most explicitly documented traditional uses of this plant. Drugs.com specifically cites this traditional use. No clinical trials have confirmed efficacy for dandruff.
Shea butter is traditionally used for scalp health and dandruff management, with its emollient properties addressing dry-scalp-type dandruff and its anti-inflammatory and antibacterial properties potentially reducing seborrheic-type flaking. No clinical RCTs specific to shea butter for dandruff have been identified.
Native American tribes — including Navajo, Zuni, and others — historically washed hair with yucca root decoctions to treat dandruff, leveraging the plant's saponin-rich lather as a natural antifungal and cleansing shampoo. This use is documented across multiple ethnobotanical and clinical reference sources including PeaceHealth and Encyclopedia.com. No modern clinical trial has evaluated yucca specifically for dandruff.
Go back